Related Experiment Video
Updated: Aug 1, 2025

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Prior COVID-19 Immunization Does Not Cause IgA- or IgG-Dependent Enhancement of SARS-CoV-2 Infection
Melyssa Yaugel-Novoa1, Blandine Noailly1, Fabienne Jospin1
1CIRI-Centre International de Recherche en Infectiologie, Team GIMAP, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, F42023 Saint-Etienne, France.
Abstract:
Antibody-dependent enhancement (ADE) can increase the rates and severity of infection with various viruses, including coronaviruses, such as MERS. Some in vitro studies on COVID-19 have suggested that prior immunization enhances SARS-CoV-2 infection, but preclinical and clinical studies have demonstrated the contrary. We studied a cohort of COVID-19 patients and a cohort of vaccinated individuals with a heterologous (Moderna/Pfizer) or homologous (Pfizer/Pfizer) vaccination scheme. The dependence on IgG or IgA of ADE of infection was evaluated on the serum samples from these subjects (twenty-six vaccinated individuals and twenty-one PCR-positive SARS-CoV-2-infected patients) using an in vitro model with CD16- or CD89-expressing cells and the Delta (B.1.617.2 lineage) and Omicron (B.1.1.529 lineage) variants of SARS-CoV-2. Sera from COVID-19 patients did not show ADE of infection with any of the tested viral variants. Some serum samples from vaccinated individuals displayed a mild IgA-ADE effect with Omicron after the second dose of the vaccine, but this effect was abolished after the completion of the full vaccination scheme. In this study, FcγRIIIa- and FcαRI-dependent ADE of SARS-CoV-2 infection after prior immunization, which might increase the risk of severe disease in a second natural infection, was not observed.
Insights
Antibody-dependent enhancement (ADE) of SARS-CoV-2 infection was not observed in COVID-19 patients or fully vaccinated individuals. Mild IgA-ADE effects in vaccinated individuals were transient and disappeared after completing the vaccination scheme.
Area of Science:
- Immunology
- Virology
- Infectious Diseases
Background:
- Antibody-dependent enhancement (ADE) is a phenomenon where antibodies enhance viral infection.
- Concerns exist regarding potential ADE of SARS-CoV-2 following vaccination or prior infection.
- Previous studies yielded conflicting results on ADE in COVID-19.
Purpose of the Study:
- To investigate antibody-dependent enhancement (ADE) of SARS-CoV-2 infection in COVID-19 patients and vaccinated individuals.
- To evaluate the role of IgG and IgA in potential ADE with SARS-CoV-2 variants.
- To assess ADE risk after homologous and heterologous vaccination schemes.
Main Methods:
- Serum samples from 21 COVID-19 patients and 26 vaccinated individuals were analyzed.
- An in vitro model using CD16- or CD89-expressing cells was employed.
- Infection enhancement by serum antibodies against SARS-CoV-2 Delta and Omicron variants was assessed.
Main Results:
- Sera from COVID-19 patients did not induce ADE with any tested SARS-CoV-2 variants.
- A mild IgA-dependent ADE effect was observed with Omicron in some vaccinated individuals after the second dose.
- This mild ADE effect was abolished after the full vaccination scheme was completed.
Conclusions:
- The study did not observe FcγRIIIa- and FcαRI-dependent ADE of SARS-CoV-2 infection in COVID-19 patients or fully vaccinated individuals.
- Prior immunization does not appear to increase the risk of severe disease through ADE.
- The findings suggest that current vaccination strategies do not lead to significant ADE of SARS-CoV-2 infection.
Related Concept Videos
Vaccinations
Immunological Memory
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...

